Biotin-Containing Polymeric Surfaces for Rapid Protein Capture

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Biotinylated chromatography resins for isolating biotin-binding proteins face diffusion limitations due to biotin groups being predominantly located within the interior structure of porous resins, necessitating long residence times for capture.

Innovation Solution

Development of biotin-containing monomers and polymeric materials with biotin-containing monomeric units that are irreversibly attached to a substrate, allowing for efficient affinity capture of biotin-binding proteins in a one-step process.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If biotin-containing groups are located within the interior structure of porous resin, then the resin can provide high binding capacity, but diffusion limitations occur resulting in long residence times

Engineering Contradiction:
Improvebinding capacityVSAvoidresidence time
Core Design Contradiction:
Quantity of substanceVSLoss of time

Solution Approach 1:

The patent transitions from three-dimensional porous resin structures to two-dimensional planar substrates (membranes, sheets, or flat surfaces). This dimensional change eliminates the interior structure that causes diffusion limitations while maintaining high binding capacity through dense surface functionalization with biotin-containing groups.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Solution Approach 2:

The invention extracts the biotin-containing functional groups from the interior of porous resins and relocates them to the surface of planar substrates. This extraction eliminates the diffusion barrier created by interior positioning while preserving the binding functionality through surface-level placement.

Inventive Principle:
Principle #2Taking out (Extraction)

2Quantity of substance

If biotin molecule is coupled to substrate using chemical activation or biotinylation agents, then binding capacity is improved, but process complexity increases with multiple steps and expensive reagents

Engineering Contradiction:
Improvebinding capacityVSAvoidprocess complexity
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The patent employs self-service through the inherent reactivity of the monomer's functional groups. The biotin-containing monomers possess reactive groups that automatically form covalent bonds with substrate functional groups without requiring external activation agents or complex multi-step chemistry, thereby simplifying the process while maintaining high binding capacity.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The invention merges the substrate preparation and biotin coupling steps into a single direct covalent bonding operation. By designing monomers with built-in reactive functionality, the patent combines what were previously separate steps (substrate activation, reagent addition, coupling) into one integrated process.

Inventive Principle:
Principle #5Merging (Combining)

3Reliability

If conventional biotinylation methods are used, then biotin binding is achieved, but scalability is limited due to multistep reactions and expensive reagents

Engineering Contradiction:
Improvebiotin bindingVSAvoidscalability
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The self-reactive monomers perform their own coupling function without requiring external reagents, making the process inherently scalable. The elimination of expensive, sensitive reagents and multiple manual steps enables automation and large-scale production while maintaining reliable biotin binding performance.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent changes the chemical parameters of the coupling reaction by using monomers with inherently reactive functional groups that undergo direct covalent bonding. This parameter change from complex multi-step chemistry to simple direct bonding enables scale-up and roll-to-roll processing.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution enables rapid and efficient capture of biotin-binding proteins, overcoming diffusion limitations and reducing the need for long exposure times, while being amenable to scale-up and roll-to-roll processing.

Implementation Method 1

polymerizable composition comprising the biotin-containing monomer of Formula (I)... polymerizing the polymerizable composition to form a polymeric material

Methodology Applied
Scientific EffectPolymerization: Photopolymerisation

Implementation Method 2

the polymeric material is irreversibly attached to the substrate

Methodology Applied
Scientific EffectCovalent bonding: Chemical Bonding

Implementation Method 3

Biotin is known to interact strongly, even irreversibly, with proteins such as avidin, streptavidin, and tamavidin... binding the biotin-binding proteins to the article

Methodology Applied
Scientific EffectAffinity binding: Adsorption

Data Source

PatentUS12528824B2Biotin-containing monomers and articles formed therefrom
Publication Date: 2026.01.20 SOLVENTUM INTELLECTUAL PROPERTIES CO
  • US12528824B2 patent drawing
  • US12528824B2 patent drawing
  • US12528824B2 patent drawing

AI summary

Biotin-containing monomers, polymeric materials formed from the biotin-containing monomers, articles containing the polymeric materials, methods of making the articles, and methods of using the articles are provided. The articles can be used, for example, for affinity capture of biotin-binding proteins, including biotin-binding fusion proteins (i.e., a biotin-binding protein fused to another biomaterial). Articles that contain captured biotin-binding proteins can be further used for affinity capture of various biotin-containing biomaterials such as biotinylated proteins. The articles can also be used, for example, for affinity capture of biotin-binding fusion proteins where the fusion protein includes, for example, an enzyme or antibody.